Medical Cannabis Laws and Opioid Prescribing in the Medicare Part D Population

JAMA Internal Medicine Author Interviews
02/04/2018 11 min
Medical Cannabis Laws and Opioid Prescribing in the Medicare Part D Population

Listen "Medical Cannabis Laws and Opioid Prescribing in the Medicare Part D Population"

Descargar episodio Ver en sitio original

Episode Synopsis

Interview with W. David Bradford, PhD, author of Association Between US State Medical Cannabis Laws and Opioid Prescribing in the Medicare Part D Population, Jason M Hockenberry, PhD, author of Association of Medical and Adult-Use Marijuana Laws With Opioid Prescribing for Medicaid Enrollees, and Kevin P. Hill, MD, MHS, author of The Role of Cannabis Legalization in the Opioid Crisis

More episodes of the podcast JAMA Internal Medicine Author Interviews

Targeting MASLD and MASH in the US Hispanic/Latino Population 22/09/2025
Azelastine Nasal Spray for Prevention of SARS-CoV-2 Infections 02/09/2025
Nonhormonal Treatment of Menopausal Vasomotor Symptoms 25/08/2025
The JAMA Internal Medicine Editorial Fellowship Experience 18/08/2025
Prophylactic Antibiotics for Upper Gastrointestinal Bleeding in Patients With Cirrhosis 11/08/2025
National Trends in Prolonged Emergency Department Length of Stay Among Older Adults: 2017-2024 30/06/2025
Patient-Delivered Continuous Care for Weight Loss Maintenance 27/05/2025
3 Studies From the Society of General Internal Medicine Annual Meeting 14/05/2025
Hospital Addiction Consultation Service and Opioid Use Disorder Treatment 14/04/2025
A Person-Centered Approach to Supplemental Oxygen Therapy in the Outpatient Setting 07/04/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA